A study on how the newest modulator medication elexacaftor/tezacaftor/ivacaftor affects the gut over time using MRI scans
Comparing the money spent on healthcare up to age 2 years in children with CF who are screen detected and those who are diagnosed later due to sickness.
Differences between the United States and the European Union in the time of approval of CFTR modulators for the treatment of cystic fibrosis
Evaluating the treatment outcomes of the bacteria, Mycobacterium abscessus, in people with cystic fibrosis at the Royal Papworth Hospital, UK.
Evaluating the Effectiveness of a Novel CF Medication for People Without Common Cystic Fibrosis-causing Genetic Mutations
